These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
808 related items for PubMed ID: 9020325
1. Weaning of immunosuppression in liver transplant recipients. Mazariegos GV, Reyes J, Marino IR, Demetris AJ, Flynn B, Irish W, McMichael J, Fung JJ, Starzl TE. Transplantation; 1997 Jan 27; 63(2):243-9. PubMed ID: 9020325 [Abstract] [Full Text] [Related]
2. Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Cao S, Cox KL, Berquist W, Hayashi M, Concepcion W, Hammes GB, Ojogho OK, So SK, Frerker M, Castillo RO, Monge H, Esquivel CO. Pediatr Transplant; 1999 Feb 27; 3(1):22-6. PubMed ID: 10359027 [Abstract] [Full Text] [Related]
3. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus. Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I. Transplantation; 1997 Dec 27; 64(12):1755-60. PubMed ID: 9422416 [Abstract] [Full Text] [Related]
4. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation. Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y. Transplantation; 2012 Feb 27; 93(4):437-43. PubMed ID: 22228415 [Abstract] [Full Text] [Related]
5. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis. Jain A, Mazariegos G, Pokharna R, Parizhskaya M, Kashyap R, Kosmach-Park B, Smith A, Fung JJ, Reyes J. Transplantation; 2003 Apr 15; 75(7):1020-5. PubMed ID: 12698091 [Abstract] [Full Text] [Related]
6. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I. Transplantation; 1997 Dec 27; 64(12):1695-700. PubMed ID: 9422404 [Abstract] [Full Text] [Related]
7. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group. Gruessner RW. Clin Transplant; 1997 Aug 27; 11(4):299-312. PubMed ID: 9267719 [Abstract] [Full Text] [Related]
8. Weaning of immunosuppression in long-term liver transplant recipients. Ramos HC, Reyes J, Abu-Elmagd K, Zeevi A, Reinsmoen N, Tzakis A, Demetris AJ, Fung JJ, Flynn B, McMichael J. Transplantation; 1995 Jan 27; 59(2):212-7. PubMed ID: 7839442 [Abstract] [Full Text] [Related]
9. Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Eghtesad B, Fung JJ, Demetris AJ, Murase N, Ness R, Bass DC, Gray EA, Shakil O, Flynn B, Marcos A, Starzl TE. Liver Transpl; 2005 Nov 27; 11(11):1343-52. PubMed ID: 16237712 [Abstract] [Full Text] [Related]
10. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J. Exp Clin Transplant; 2008 Jun 27; 6(2):113-7. PubMed ID: 18816237 [Abstract] [Full Text] [Related]
11. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus. Jain A, Kashyap R, Marsh W, Rohal S, Khanna A, Fung JJ. Transplantation; 2001 Apr 27; 71(8):1102-6. PubMed ID: 11374410 [Abstract] [Full Text] [Related]
12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC. Transpl Immunol; 2008 Nov 27; 20(1-2):32-42. PubMed ID: 18773960 [Abstract] [Full Text] [Related]
13. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study. Lerut JP, Ciccarelli O, Mauel E, Gheerardhyn R, Talpe S, Sempoux C, Laterre PF, Roggen FM, Van Leeuw V, Otte JB, Gianello P. Transpl Int; 2001 Dec 27; 14(6):420-8. PubMed ID: 11793040 [Abstract] [Full Text] [Related]
14. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE. Transplantation; 2003 Jun 27; 75(12):2048-53. PubMed ID: 12829910 [Abstract] [Full Text] [Related]
15. Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients. Włodarczyk Z, Wałaszewski J, Perner F, Vitko S, Ostrowski M, Bachleda P, Kokot F, Klinger M, Szenohradsky P, Studenik P, Navratil P, Asztalos L, Rutkowski B, Nagy KK, Hickey D. Ann Transplant; 2002 Jun 27; 7(3):28-31. PubMed ID: 12465429 [Abstract] [Full Text] [Related]
16. Improved efficacy of basiliximab over antilymphocyte globulin induction therapy in paediatric renal transplantation. Clark G, Walsh G, Deshpande P, Koffman G. Nephrol Dial Transplant; 2002 Jul 27; 17(7):1304-9. PubMed ID: 12105256 [Abstract] [Full Text] [Related]
17. Initial experience with FK506 (tacrolimus) in pediatric renal transplant recipients. McKee M, Segev D, Wise B, Case B, Neu A, Fivush B, Colombani P. J Pediatr Surg; 1997 May 27; 32(5):688-90. PubMed ID: 9165452 [Abstract] [Full Text] [Related]
18. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus). Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW. Transplant Proc; 1998 Jun 27; 30(4):1401-2. PubMed ID: 9636566 [Abstract] [Full Text] [Related]
19. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation. Tanaka K, Lake J, Villamil F, Levy G, Marotta P, Mies S, de Hemptinne B, Moench C. Liver Transpl; 2005 Nov 27; 11(11):1395-402. PubMed ID: 16237691 [Abstract] [Full Text] [Related]
20. Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Andries S, Casamayou L, Sempoux C, Burlet M, Reding R, Bernard Otte J, Buts JP, Sokal E. Transplantation; 2001 Jul 27; 72(2):267-72. PubMed ID: 11477351 [Abstract] [Full Text] [Related] Page: [Next] [New Search]